Found: 6
Select item for more details and to access through your institution.
Modulation of imidazoline I<sub>2</sub> binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 15, p. 3693, doi. 10.1111/bph.12728
- By:
- Publication type:
- Article
Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis.
- Published in:
- Journal of Pain Research, 2017, v. 10, p. 1033, doi. 10.2147/JPR.S132026
- By:
- Publication type:
- Article
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats.
- Published in:
- Journal of Pain Research, 2012, v. 5, p. 151, doi. 10.2147/JPR.S32122
- By:
- Publication type:
- Article
Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain.
- Published in:
- Journal of Pain Research, 2011, v. 4, p. 111, doi. 10.2147/JPR.S18353
- By:
- Publication type:
- Article
Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent models.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacological characterisation of CR6086, a potent prostaglandin E<sub>2</sub> receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, p. 1, doi. 10.1186/s13075-018-1537-8
- By:
- Publication type:
- Article